PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED)

• Status: Completed
• Trial end date: 2003-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 3 to 6 months of age with bronchiolitis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Montelukast

Criteria

Inclusion Criteria :

• Active bronchiolitis or a history of bronchiolitis and asthma-like symptoms

Exclusion Criteria :

• A history of any significant illness that will pose additional risk to the patient